1. Home
  2. PTGX vs GMED Comparison

PTGX vs GMED Comparison

Compare PTGX & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protagonist Therapeutics Inc.

PTGX

Protagonist Therapeutics Inc.

HOLD

Current Price

$150.62

Market Cap

9.5B

Sector

Health Care

ML Signal

HOLD

Logo Globus Medical Inc.

GMED

Globus Medical Inc.

HOLD

Current Price

$83.85

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PTGX
GMED
Founded
2006
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.5B
11.0B
IPO Year
2016
2012

Fundamental Metrics

Financial Performance
Metric
PTGX
GMED
Price
$150.62
$83.85
Analyst Decision
Strong Buy
Buy
Analyst Count
13
14
Target Price
$108.23
$100.42
AVG Volume (30 Days)
456.0K
1.3M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
422.67
EPS
2.35
2.00
Revenue
N/A
$2,938,931,000.00
Revenue This Year
$874.25
$11.13
Revenue Next Year
N/A
$6.28
P/E Ratio
$64.08
$41.48
Revenue Growth
N/A
16.65
52 Week Low
$57.45
$54.17
52 Week High
$160.81
$101.40

Technical Indicators

Market Signals
Indicator
PTGX
GMED
Relative Strength Index (RSI) 54.34 48.59
Support Level $94.48 $74.52
Resistance Level $160.81 $87.55
Average True Range (ATR) 5.13 2.60
MACD -0.92 -0.36
Stochastic Oscillator 25.63 23.04

Price Performance

Historical Comparison
PTGX
GMED

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a biopharmaceutical company engaged in the discovery and development of peptide-based therapeutics using its proprietary technology platform. The company focuses on three therapeutic areas: inflammation and immunology, hematology, and metabolic diseases. Its pipeline includes clinical-stage and preclinical candidates such as rusfertide for polycythemia vera, icotrokinra for inflammatory diseases, and other programs targeting IL-17, obesity, and iron metabolism disorders, developed through internal research and strategic collaborations.

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

Share on Social Networks: